Sort
3,198 grants matching “mrna vaccine”
CLONING HIV-1-NEUTRALIZING FABS FROM LN TISSUE SECTIONS
$261,000Beth Israel Deaconess Medical Center · R21 · FY2000 · AI
Developing RNA Vaccines to Treat Peanut Hypersensitivity
$260,780Herman F. Staats · Duke University · R21 · FY2023 · AI
Interference by Defective influenza Viruses
$260,604Debi P. Nayak · University Of California Los Angeles · R01 · FY2006 · AI
Novel Approaches to the Assessment of Oral Mucosal Immu*
$260,021University Of Pittsburgh At Pittsburgh · R21 · FY2003 · DE
Development of a chimeric mouse model for the analysis of Plasmodium liver stages
$259,875John B. Sacci · University Of Maryland Baltimore · R21 · FY2006 · AI
Rewiring SARS-CoV Genome Organization and Pathogenesis
$259,764Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2007 · AI
Ribosome Profiling in Plasmodium falciparum
$259,440Marilyn Parsons · Seattle Biomedical Research Institute · R21 · FY2013 · AI
MOLECULAR GENETIC ANALYSIS OF MALARIA ANTIGENS
$258,561Loyola University Of Chicago · R01 · FY2001 · AI
Biochemical Mechanisms of Enzyme Action and Cellular Regulation
$258,482P. Boon Chock · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
MOLECULAR GENETIC ANALYSIS OF MALARIA ANTIGENS
$258,200Loyola University Of Chicago · R01 · FY2002 · AI
Project 2: Current Good Manufacture Practices (CGMP) Production of Nucleoside-Modified mRNAs Encoding HIV-1 Envelopes
$257,560Frederick Porter · Duke University · U19 · FY2020 · AI
Rewiring SARS-CoV Genome Organization and Pathogenesis
$257,344Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2008 · AI
Small molecule inhibitors targeting the SARS-CoV-2 pathogenicity factor Nsp1
$257,283Anna-Lena Steckelberg · Columbia University Health Sciences · R21 · FY2022 · AI
Control of Paramyxovirus RNA Synthesis
$257,189Wake Forest University Health Sciences · R01 · FY2004 · AI
Core B: Animal Core
$257,035Stefan Niewiesk · Washington University · P01 · FY2025 · CA
Discovery of Molecular Probes and Therapeutic Leads, Administrative Supplement on HPV
$256,851Joseph M Fox · University Of Delaware · P20 · FY2023 · GM
Fox COBRE Phase II Admin Core
$256,851Joseph M Fox · University Of Delaware · P20 · FY2023 · GM
mRNA/miRNA Regulation of Host Resistance and Control in HIV-1 Discordant Couples
$256,600Jairam Rao Lingappa · University Of Washington · R21 · FY2010 · AI
The impact of mucociliary clearance on Mycobacterium tuberculosis pathogenesis
$256,475Javeed Ali Shah · University Of Washington · R21 · FY2023 · AI
The Neuroprotective Effect of HSP72 Induction in Experimental Glaucoma
$256,133Natik Piri · University Of California Los Angeles · R01 · FY2011 · EY
The Neuroprotective Effect of HSP72 Induction in Experimental Glaucoma
$256,133Natik Piri · University Of California Los Angeles · R01 · FY2012 · EY
SBIR Phase I: At home, single dose mRNA vaccine patch (COVID-19)
$256,000Kathryn Kosuda · Vaxess Technologies, Inc. · · FY2020 · TIP
STTR Phase I: Formulation of a COVID-19 mRNA Vaccine by Inverse Flash NanoPrecipitation
$256,000Robert Pagels · Optimeos Life Sciences, Inc. · · FY2020 · TIP
Transient Gene Therapy as Broad Spectrum Antiviral
$255,932Dusan Bogunovic · Lab11 Therapeutics, Llc · R41 · FY2021 · AI
REDUCED CYTOKINE PRODUCTION BY NEONATAL T CELLS
$255,753Stanford University · R01 · FY2000 · HD